Welcome to our dedicated page for Digital Health Acquisition Warrant news (Ticker: DHACW), a resource for investors and traders seeking the latest updates and insights on Digital Health Acquisition Warrant stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Digital Health Acquisition Warrant's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Digital Health Acquisition Warrant's position in the market.
Summary not available.
Summary not available.
Summary not available.
Digital Health Acquisition Corp. (NASDAQ: DHAC) announced an extension of its initial business combination deadline from February 8, 2023, to May 8, 2023. This marks the first of three potential three-month extensions allowed by the governing documents, granting the company additional time to finalize its merger with target companies, including VSee Labs, a telehealth solution provider, and iDoc Virtual Telehealth Solutions, focusing on acute care via telehealth. Digital Health raised $115 million during its IPO in November 2021 to acquire scalable healthcare businesses.
Digital Health Acquisition Corporation (NASDAQ: DHAC) has signed a definitive agreement to acquire VSee Lab, Inc. and iDoc Telehealth Solutions, creating VSee Health, Inc. The merger, valued at approximately $110 million, aims to enhance telehealth capabilities and expand market reach. VSee offers a customizable, HIPAA-compliant SaaS platform, while iDoc specializes in neurocritical care. Completion of the transaction is anticipated in Q3 2022, pending shareholder approval and regulatory conditions.
Digital Health Acquisition Corp. announced that starting on December 30, 2021, holders of units from its initial public offering can separately trade shares of common stock and warrants on Nasdaq. The common stock will trade under the symbol DHAC, and warrants under DHACW. Units that are not separated will continue trading under DHACU. The IPO was successfully completed on November 8, 2021, with A.G.P./Alliance Global Partners as the sole book-running manager. This step provides investors with greater flexibility in their trading options.
Digital Health Acquisition Corp. (NASDAQ: DHACU) has successfully closed its initial public offering, raising $115 million by offering 11,500,000 units at $10.00 each. This includes the full exercise of an over-allotment option for an additional 1,500,000 units. Each unit comprises one share of common stock and one redeemable warrant, allowing purchase of additional shares at $11.50. Trading under DHACU commenced on November 4, 2021, with plans for separate listings for common stock (DHAC) and warrants (DHACW) once available. The company aims to merge with tech-focused healthcare businesses valued between $175 million and $500 million.
Digital Health Acquisition Corp. has priced its initial public offering (IPO) at $10.00 per unit, consisting of one share of common stock and one redeemable warrant. A total of 10,000,000 units will be offered, with trading on Nasdaq under the ticker symbols DHACU, DHAC, and DHACW commencing on November 4, 2021. The IPO is expected to close on November 8, 2021, subject to customary conditions. The company targets established healthcare tech businesses with an enterprise value of $175 million to $500 million.